078140 — Daebongls Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Daebongls Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	82,957	93,504	87,622	93,954	102,064
Cost of Revenue
Gross Profit	23,576	24,959	21,445	26,795	28,495
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	73,272	85,330	83,821	84,900	94,782
Operating Profit	9,686	8,174	3,801	9,054	7,281
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	12,195	10,713	6,305	11,166	14,739
Provision for Income Taxes
Net Income After Taxes	10,042	11,794	6,182	9,687	11,942
Minority Interest
Net Income Before Extraordinary Items
Net Income	6,789	8,628	4,182	7,339	10,059
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	6,789	8,628	4,182	7,339	10,059
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	619	787	383	671	921
Dividends per Share